A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2013
12/04/2013	CN102600457B Compound propolis composition used for treating pig viral diarrhea and preparation method thereof
12/04/2013	CN102600259B Complex propolis composition for treating eperythrozoon suis and preparation method thereof
12/04/2013	CN102585012B Preparation method for grouper alpha interferon derivative and application
12/04/2013	CN102552647B Traditional Chinese medicine preparation for treating canine parvoviral enteritis and preparation method of traditional Chinese medicine preparation
12/04/2013	CN102552600B Traditional Chinese medicine for preventing and treating chicken infectious laryngotracheitis and production method thereof
12/04/2013	CN102552554B Chinese medicinal extract with anti-allergic effect as well as preparation method and application thereof
12/04/2013	CN102552429B Chinese medicinal herb fish medicament for preventing and treating fish diseases
12/04/2013	CN102526657B Compound propolis composition for treating porcine proliferative enteropathy and preparation method thereof
12/04/2013	CN102430098B Compound propolis composition for treating swine streptococcicosis and preparation method thereof
12/04/2013	CN102429842B Production process of environment-friendly finger moistening paste
12/04/2013	CN102423357B Compound propolis composition spray for treating livestock foot-and-mouth disease and its preparation method
12/04/2013	CN102397473B Composite propolis composition for treating gosling plague and preparation method thereof
12/04/2013	CN102397330B Compound oil-in-water schizonepeta spike oil nanoemulsion composition and preparation method thereof
12/04/2013	CN102320947B Polyphenol compound contained in tobacco, preparation method and application thereof
12/04/2013	CN102295643B 2-(pyridin-2-ylamino)-pyrido[2,3d]pyrimidin-7-ones
12/04/2013	CN102268020B Ceftiofur acetoxy ethyl ester and preparation method thereof
12/04/2013	CN102139101B Application of protein Com1 in immunoprotection of coxiella burnetii
12/04/2013	CN102038950B Novel immune adjuvant and vaccine containing same
12/04/2013	CN102028944B Combination vaccines with low dose of HIB conjugate
12/04/2013	CN102001921B Sesquiterpene hybrid hydroquinone compounds and preparation method and application thereof
12/04/2013	CN101951958B Cholesterol derivatives of inhibitors of viral fusion
12/04/2013	CN101926993B Adjuvant systems and vaccines
12/04/2013	CN101897966B Cynomorium songaricum immunological adjuvant and influenza vaccine comprising same
12/04/2013	CN101890048B Total bile acid extract of bear bile powder and preparation method and application of injection thereof
12/04/2013	CN101889987B Method for preparing novel cefixime tablets and cefixime capsules
12/04/2013	CN101775005B Cadrofloxacin hydrochloride-I crystal and preparation method thereof
12/04/2013	CN101775003B Benzothiophene derivative, preparation method and application thereof
12/04/2013	CN101676284B Preparation method of nifuratel with high purity
12/04/2013	CN101646664B Furanone compounds
12/04/2013	CN101472585B Antibacterial compositions
12/03/2013	US8598354 Compounds having antiparasitic or anti-infectious activity
12/03/2013	US8598324 Anti-pathogen treatments
12/03/2013	US8598318 Modified human thymic stromal lymphopoietin
12/03/2013	US8598176 Pyridazine compound and use thereof
12/03/2013	US8598114 Antimicrobial compounds
12/03/2013	US8597876 Method of treating HIV infection
12/03/2013	US8597665 Chimeric immunomodulatory compounds and methods of using the same-IV
12/03/2013	US8597619 Thickener or gellant for oil materials, gel composition comprising same, and method of producing cosmetic material or topical agent
12/03/2013	CA2694235C Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
12/03/2013	CA2691917C Crystalline pyridazine compound
12/03/2013	CA2684165C Oligonucleotide-prolyethylene glycol compound
12/03/2013	CA2615049C Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
12/03/2013	CA2539457C Nucleic acid and gene derived from novel hcv strain and replicon-replicating cell using said gene
12/03/2013	CA2491607C Plant peptide with antimicrobial activity
12/03/2013	CA2474497C Compositions and methods related to tim-3, a th1-specific cell surface molecule
12/03/2013	CA2304796C Hepatitis c receptor protein cd81
11/2013
11/30/2013	CA2779052A1 Pharmaceutical composition of entecavir and process of manufacturing
11/28/2013	WO2013177397A1 Multivalent meningococcal conjugates and methods for preparing cojugates
11/28/2013	WO2013177275A1 Cranberry xyloglucan oligosaccharide composition
11/28/2013	WO2013177195A1 3',5'-cyclic phosphate prodrugs for hcv infection
11/28/2013	WO2013177142A1 Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission
11/28/2013	WO2013177099A1 Method for treating infectious diseases using emissive energy
11/28/2013	WO2013176622A1 A dry powder formulation
11/28/2013	WO2013176563A1 Biologically active peptide complexes
11/28/2013	WO2013175415A1 Substituted pyrimidine compounds and uses thereof
11/28/2013	WO2013175172A1 Therapeutic for treating clostridium difficile infection
11/28/2013	WO2013174962A1 Uracyl spirooxetane nucleosides
11/28/2013	WO2013174947A1 Inhibitors of the activity of complex (iii) of the mitochondrial electron transport chain and use thereof
11/28/2013	WO2013174931A1 7-oxo-4,7 -dihydro- pyrazolo [1, 5 -a] pyrimidine derivatives which are useful in the treatment, amelioration or prevention of a viral disease
11/28/2013	WO2013174930A2 7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
11/28/2013	WO2013174832A1 Meningococcus serogroup x conjugate
11/28/2013	WO2013174015A1 Cefixime granule and preparation method thereof
11/28/2013	WO2013174003A1 Compositions and methods related to prevention and treatment of rabies infection
11/28/2013	WO2013173960A1 Traditional chinese medicine composition for treating lower respiratory tract viral infectious diseases and preparation method therefor
11/28/2013	WO2013173941A1 Peptide and the use thereof
11/28/2013	WO2013173910A1 A novel toxin in type a clostridium perfringens
11/28/2013	WO2013152065A3 1,8-naphthyridin-2(1h)-one derivatives as cytomegalovirus inhibitors
11/28/2013	WO2013122375A9 Pharmaceutical composition for viral treatment, and method for screening antiviral agent
11/28/2013	US20130316945 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
11/28/2013	US20130315951 Compositions and methods for stimulating an immune response against infectious agents
11/28/2013	US20130315949 Molecular Antigen Array
11/28/2013	US20130315946 Vaccine composition against streptococcus pyogenes infection
11/28/2013	US20130315869 Bacteriophages for reducing toxicity of bacteria
11/28/2013	US20130315863 Methods and compositions for treating flaviviridae infections
11/28/2013	US20130315862 Methods and compositions for treating hepatitis c virus
11/28/2013	DE10144906B4 Verfahren zur großtechnischen Herstellung von Impfstoffen A process for the large scale production of vaccines
11/28/2013	CA2874258A1 Peptide and the use thereof
11/27/2013	EP2666784A2 Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
11/27/2013	EP2666774A1 Beta-lactamase Inhibitors
11/27/2013	EP2666466A1 Process for production of nk-cell-enriched blood preparation
11/27/2013	EP2665816A1 Biologically active nucleotide molecules for selectively killing off cells, use thereof, and application kit
11/27/2013	EP2665738A1 Compounds for use in the treatment of bacterial infection
11/27/2013	EP2665708A2 Modulators of tlr3/dsrna complex and uses thereof
11/27/2013	CN103415341A Copper-and-titanium-containing composition and production method therefor
11/27/2013	CN103415290A Compounds useful for treating AIDS
11/27/2013	CN103409465A Preparation method and application of recombinant human leucocyte interleukin 27
11/27/2013	CN103409455A Egg yolk antibody anti-human enterotoxigenic escherichia coli adhesion protein and application thereof
11/27/2013	CN103409454A Preparation method of JEV (Japanese encephalitis virus) dominant antigen epitope E1-402aa recombinant plasmid and vaccine
11/27/2013	CN103409453A Preparation method of recombinant panda IL-6 immunological adjuvant
11/27/2013	CN103409384A Prawn protein with antiviral activity and application of prawn protein
11/27/2013	CN103409377A Preparation and use of canine parvovirus virus-like particles
11/27/2013	CN103409376A JEV (Japanese Encephalitis Virus) / WNV (West Nile Virus) chimeric virus and application thereof
11/27/2013	CN103409374A Trigeminy inactivated vaccine for porcine circovirus disease, porcine streptococcus suis disease and porcine haemophilus parasuis disease, preparation method of the vaccine and applications of the vaccine
11/27/2013	CN103409364A Culture medium suitable for preparing porcine circovirus type II vaccine through PK15 cell and using method thereof
11/27/2013	CN103409359A Prokaryotic expression strain of TREM-1 extracellular domain, and application of prokaryotic expression strain in treating septicemia caused by streptococcus suis infection.
11/27/2013	CN103409334A Lactobacillus for inhibiting pathogenic bacteria of vaginitis and application thereof
11/27/2013	CN103409237A Method used for extracting chamomille extract by supercritical carbon dioxide extraction
11/27/2013	CN103408660A Monoclonal antibody of antiplague bacillus F1 antigen and application of monoclonal antibody
11/27/2013	CN103408652A Novel anti-HBV endogenous protein HNF1alpha and application thereof
11/27/2013	CN103408642A Vibrio harveyi outer membrane protein and application thereof

1 ... 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 ... 1798